Kapake

Paracetamol and Codeine Phosphate, the active ingredient in Kapake, is an analgesic (combination opioid and non‑opioid) presented as an oral tablet for systemic use. It treats moderate to severe pain in adults, providing both antipyretic and opioid‑mediated relief.

GNH USA supplies Kapake as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kapake, containing paracetamol and codeine phosphate, is indicated for pain management across several clinical situations.

- Acute postoperative pain: provides effective analgesia after surgical procedures. - Dental pain: reduces discomfort following extractions or other dental work. - Musculoskeletal pain: alleviates pain from sprains, strains, or osteoarthritis flare‑ups.

Kapake may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Constipation: reduced bowel motility. - Drowsiness: increased sleepiness. - Dizziness: sensation of light‑headedness. - Vomiting: occasional emesis. - Sweating: excessive perspiration.

Serious or Rare Side Effects: - Respiratory depression: reduced breathing effort, especially at high doses. - Dependence or addiction: potential for misuse with prolonged use. - Allergic reactions: rash, itching, or angioedema. - Hepatic injury: rare liver enzyme elevation. - Seizures: infrequent but possible in susceptible individuals. - Severe hypotension: marked drop in blood pressure.

When prescribing Kapake, clinicians should consider several safety measures.

- Assess pain severity: ensure the combination is appropriate for the level of pain. - Avoid in severe respiratory depression: risk of further breathing compromise. - Monitor for dependence: watch for signs of misuse with prolonged therapy. - Use caution in hepatic impairment: paracetamol metabolism may be reduced. - Avoid concomitant CNS depressants: increased sedation risk. - Store at ambient temperature: keep in the original pack, protect from moisture.

Kapake can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Other opioids: additive respiratory depression. - Benzodiazepines or CNS depressants: heightened sedation and respiratory risk. - Alcohol: increased central nervous system depression.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine): may raise codeine levels. - Antidepressants (SSRIs/SNRIs): potential for serotonin syndrome. - Antihistamines: may enhance drowsiness.